» Articles » PMID: 9453425

A Comparative Study Between Carbohydrate-deficient Transferrin and Gamma-glutamyltransferase for the Diagnosis of Excessive Drinking in a Liver Unit

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 1998 Feb 7
PMID 9453425
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To compare the efficacy of carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive alcohol intake in patients admitted in a liver unit.

Methods: The 346 patients were divided into three groups of alcoholics: 57 patients (31 men, 26 women) with a normal liver, 77 patients (51 men, 26 women) with non-cirrhotic alcoholic liver disease, and 61 patients (43 men, 18 women) with alcoholic cirrhosis; and three groups of non-alcoholics: 35 abstainers (21 men, 14 women), and 58 healthy blood donors (26 men, 32 women), and 58 patients (32 men, 26 women) who had a non-alcoholic liver disease. Carbohydrate-deficient transferrin and gamma-glutamyltransferase were measured at admission using commercially available kits.

Results: Carbohydrate-deficient transferrin was more sensitive than gamma-glutamyltransferase in patients without alcoholic liver disease, in both men (85 vs 54%) and women (64 vs 36%). Carbohydrate-deficient transferrin sensitivity decreased slightly but not significantly according to the severity of the liver disease in men and women. The sensitivity of gamma-glutamyltransferase which was low in men and women without alcoholic liver disease, improved in groups with moderate or severe alcoholic liver disease: not less than 80% in men and up to 100% in women. The specificity of carbohydrate-deficient transferrin in patients with non-alcoholic liver disease was consistently higher than that of gamma-glutamyltransferase (80% vs 60%).

Conclusions: In liver units, carbohydrate-deficient transferrin can help to identify excessive drinkers without liver disease with a higher efficacy than that of gamma-glutamyltransferase; carbohydrate-deficient transferrin can also be used to distinguish between alcoholics with moderate liver disease and patients with non-alcoholic liver diseases.

Citing Articles

Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.

Niu X, Zhu L, Xu Y, Zhang M, Hao Y, Ma L BMC Public Health. 2023; 23(1):859.

PMID: 37170239 PMC: 10173666. DOI: 10.1186/s12889-023-15749-x.


Focus on alcoholic liver disease: from nosography to treatment.

Streba L, Vere C, Streba C, Ciurea M World J Gastroenterol. 2014; 20(25):8040-7.

PMID: 25009375 PMC: 4081674. DOI: 10.3748/wjg.v20.i25.8040.


Evaluation of the oxidative stress in chronic alcoholics.

Singh M, Gupta S, Singhal U, Pandey R, Aggarwal S J Clin Diagn Res. 2013; 7(8):1568-71.

PMID: 24086841 PMC: 3782898. DOI: 10.7860/JCDR/2013/5596.3210.


Utility of a new model to diagnose an alcohol basis for steatohepatitis.

Dunn W, Angulo P, Sanderson S, Jamil L, Stadheim L, Rosen C Gastroenterology. 2006; 131(4):1057-63.

PMID: 17030176 PMC: 2483536. DOI: 10.1053/j.gastro.2006.08.020.